ERG and prostate cancer: Although there were some differential molecular effects of NSAID treatments in both mouse models, these molecular changes could not collectively establish the biological basis of the strong efficacy of both aspirin and naproxen NSAID treatments in reducing PCa tumorigenesis in only the TMPSS2-ERG fusion-driven prostate cancer model and not in the non-fusion-driven PCa model.